INTERVENTIONALPROTOCOL REGISTERED2005-005263-29
Multiple Sclerosis and Extract of Cannabis (MUSEC): A randomised, double-blind, placebo-controlled phase III trial to determine the efficacy and safety of a standardised oral extract of Cannabis sa...
Multiple Sclerosis
Locally preserved from EU Clinical Trials Register (EudraCT)Open EU Clinical Trials Register (EudraCT)↗last source update not reported
What this record can show
Protocol only - no registry results posted
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Study at a glance
- Phase
- Not reported
- Enrollment
- Not reported
- Start date
- 2006-01-31
- Sponsor
- Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research) [...] 1. Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research) 2. WELEDA AG
- Design
- Not reported
- Locations
- 0
- Results record
- Not present in registry snapshot
Multiple SclerosisMultiple Sclerosis
Linked local records
Related local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Cannabinoids and active compounds
No governed compound link was found.
Medicines
No exact medicine-name link was found.
Interventions
What was registered
No structured intervention was reported.
Eligibility
Population and criteria
- Sex
- Not reported
- Minimum age
- Not reported
- Maximum age
- Not reported
- Healthy volunteers
- Not reported
No structured eligibility criteria were reported.
Publications
Locally readable linked articles
No exact PMID-linked public article is currently readable locally.
Snapshot provenance
- Snapshot
- 7c5186db-1a87-4194-80c0-fa772522399b
- Retrieved
- 14/09/2026, 10:41:25
- SHA-256
- efb5fe5391efa0e564779bc7297f6d8767eab5cbd2c925df05c58cebf5c7499c